GESPA: classifying nsSNPs to predict disease association.

Area of Science:

• Bioinformatics
• Genetics
• Computational Biology

Background:

• Non-synonymous single nucleotide polymorphisms (nsSNPs) are common DNA variations linked to human diseases.
• Accurate clinical significance determination of nsSNPs is crucial but current methods are costly and time-consuming.
• Existing computational tools lack the accuracy and features needed for clinical nsSNP classification.

Purpose of the Study:

• To develop GESPA (Genomic Single nucleotide Polymorphism Analyzer), a novel bioinformatics program.
• To predict the pathogenicity and disease phenotype of nsSNPs with high accuracy.
• To provide a user-friendly and efficient tool for clinical use.

Main Methods:

• GESPA analyzes amino acid conservation in orthologs and paralogs.
• It integrates data from medical literature for pathogenicity prediction.
• The software was developed and validated using humsavar, ClinVar, and humvar datasets.

Main Results:

• GESPA accurately predicts nsSNP pathogenicity, outperforming existing computational methods.
• It uniquely predicts the disease phenotype associated with nsSNPs.
• The software offers enhanced usability through fast SQL-based cloud data storage and retrieval.

Conclusions:

• GESPA is an innovative bioinformatics tool for determining nsSNP pathogenicity and phenotypes.
• It is expected to serve as a valuable clinical framework for predicting nsSNP disease associations.
• The GESPA program, including source code and documentation, is publicly available.